Stock listing

A2H7JK Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: A2H7JK · LSX · EUR · DE

A2H7JK:LSX represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer. The company is actively engaged in clinical trials and research to advance its product pipeline, which includes therapies aimed at various types of tumors. Recent news highlights Telix's progress in regulatory filings and collaborations that may enhance its market position. Investors can stay informed about upcoming events and announcements that could impact the company's growth trajectory.

A2H7JK:LSXEURDEUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
A2H7JK:LSX
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Telix Pharmaceuticals Limited A2H7JK:LSX stock context

A2H7JK:LSX represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer. The company is actively engaged in clinical trials and research to advance its product pipeline, which includes therapies aimed at various types of tumors. Recent news highlights Telix's progress in regulatory filings and collaborations that may enhance its market position. Investors can stay informed about upcoming events and announcements that could impact the company's growth trajectory.

Research Telix Pharmaceuticals Limited

Alternate listings